Determinants and impact of alexithymia on quality of life in Parkinson's disease

Aarsland, 2009, Neuropsychiatric symptoms in Parkinson's disease, Mov Disord, 24, 2175, 10.1002/mds.22589 Balestrino, 2017, Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease, J Neurol Sci, 373, 173, 10.1016/j.jns.2016.12.060 Ricciardi, 2015, Alexithymia in neurological disease: a review, J Neuropsychiatry Clin Neurosci, 27, 179, 10.1176/appi.neuropsych.14070169 Taylor, 1997 Costa A, Peppe A, Carlesimo GA, Salamone G, Caltagirone C. Prevalence and characteristics of alexithymia in Parkinson's disease. Psychosomatics. 51:22–8. https://doi.org/10.1176/appi.psy.51.1.22. Poletti, 2011, Alexithymia is associated with depression in de novo Parkinson's disease, Psychother Psychosom, 80, 251, 10.1159/000322029 Assogna, 2016, Alexithymia in Parkinson's disease: a systematic review of the literature, Parkinsonism Relat Disord, 28, 1, 10.1016/j.parkreldis.2016.03.021 Goerlich-Dobre, 2014, Distinct associations of insula and cingulate volume with the cognitive and affective dimensions of alexithymia, Neuropsychologia, 53, 284, 10.1016/j.neuropsychologia.2013.12.006 Goerlich-Dobre, 2015, Neuroanatomical profiles of alexithymia dimensions and subtypes, Hum Brain Mapp, 36, 3805, 10.1002/hbm.22879 Klietz, 2020, Alexithymia is associated with reduced quality of life and increased caregiver burden in Parkinson's disease, Brain Sci, 10, 401, 10.3390/brainsci10060401 Postuma, 2015, MDS clinical diagnostic criteria for Parkinson's disease, Mov Disord, 30, 1591, 10.1002/mds.26424 Martinez-Martin, 2013, Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), J Neurol, 260, 228, 10.1007/s00415-012-6624-1 Gallagher, 2012, Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease, Mov Disord, 27, 79, 10.1002/mds.23939 Chaudhuri, 2007, The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study, Mov Disord, 22, 1901, 10.1002/mds.21596 Dalrymple-Alford, 2010, The MoCA: well-suited screen for cognitive impairment in Parkinson disease, Neurology, 75, 1717, 10.1212/WNL.0b013e3181fc29c9 Jenkinson, 1997, The PDQ-8: development and validation of a short-form Parkinson's disease questionnaire, Psychol Health, 12, 805, 10.1080/08870449708406741 Bagby, 1994, The twenty-item Toronto Alexithymia Scale-I Item selection and cross-validation of the factor structure, J Psychosom Res, 38, 23, 10.1016/0022-3999(94)90005-1 Enrici, 2015, Emotion processing in Parkinson's disease: a three-level study on recognition representation, and regulation, PLoS One, 10, e0131470, 10.1371/journal.pone.0131470 Taylor, 2003, The 20-Item Toronto Alexithymia Scale IV. Reliability and factorial validity in different languages and cultures, J Psychosom Res, 55, 277, 10.1016/S0022-3999(02)00601-3 Páez, 1999, Validez psicométrica de la Escala de Alexitimia de Toronto (TAS-20): un estudio transcultural, Boletín de Psicología, 63, 55 Wise, 2000, Comparison of 26-item and 20-item versions of the Toronto Alexithymia Scale for psychiatric outpatients, Psychol Rep, 87, 127, 10.2466/pr0.2000.87.1.127 Costa, 2006, Alexithymia in Parkinson's disease is related to severity of depressive symptoms, Eur J Neurol, 13, 836, 10.1111/j.1468-1331.2006.01216.x Costa, 2007, Neuropsychological correlates of alexithymia in Parkinson's disease, J Int Neuropsychol Soc, 13, 980, 10.1017/S1355617707071329 Goerlich-Dobre, 2014, Alexithymia-an independent risk factor for impulsive–compulsive disorders in Parkinson's disease, Mov Disord, 29, 214, 10.1002/mds.25679 Alvarado-Bolaños A, Cervantes-Arriaga A, Rodríguez-Violante M, Llorens-Arenas R, Calderón-Fajardo H, Millán-Cepeda R, et al. Impact of neuropsychiatric symptoms on the quality of life of subjects with Parkinson's disease. J Parkinsons Dis. 5:541–8. https://doi.org/10.3233/JPD-150597. Castelli, 2014, Alexithymia in patients with Parkinson's disease treated with DBS of the subthalamic nucleus: a case–control study, Front Psychol, 5, 1168, 10.3389/fpsyg.2014.01168 Demartini, 2016, Psychogenic non-epileptic seizures and functional motor symptoms: a common phenomenology?, J Neurol Sci, 368, 49, 10.1016/j.jns.2016.06.045 Urbanek, 2014, Regulation of emotions in psychogenic nonepileptic seizures, Epilepsy Behav, 37, 110, 10.1016/j.yebeh.2014.06.004 Pasini, 1992, Alexithymia as related to sex, age, and educational level: results of the Toronto Alexithymia Scale in 417 normal subjects, Compr Psychiatry, 33, 42, 10.1016/0010-440X(92)90078-5 Onor, 2010, Alexithymia and aging: a neuropsychological perspective, J Nerv Ment Dis, 198, 891, 10.1097/NMD.0b013e3181fe743e Levant, 2009, Gender differences in alexithymia, Psychol Men Masc, 10, 190, 10.1037/a0015652 Bamonti, 2010, Association of alexithymia and depression symptom severity in adults aged 50 years and older, Am J Geriatr Psychiatry, 18, 51, 10.1097/JGP.0b013e3181bd1bfe Honkalampi, 2000, Depression is strongly associated with alexithymia in the general population, J Psychosom Res, 48, 99, 10.1016/S0022-3999(99)00083-5 Li, 2015, The association between alexithymia as assessed by the 20-item Toronto Alexithymia scale and depression: a meta-analysis, Psychiatry Res, 227, 1, 10.1016/j.psychres.2015.02.006 Assogna, 2012, Alexithymia is a non-motor symptom of Parkinson disease, Am J Geriatr Psychiatry, 20, 133, 10.1097/JGP.0b013e318209de07 Bogdanova, 2013, Alexithymia and Apathy in Parkinson's Disease: neurocognitive correlates, Behav Neurol, 27, 535, 10.1155/2013/682393 Sengul, 2020, Alexithymia is associated with cognitive impairment in patients with Parkinson's disease, Ideggyogy Sz, 73, 199, 10.18071/ISZ.73.0199 Chen, 2017, Prevalence and associated factors of alexithymia among adult prisoners in China: a cross-sectional study, BMC Psychiatry, 17, 10.1186/s12888-017-1443-7 Poletti, 2011, The association between motor subtypes and alexithymia in de novo Parkinson's disease, J Neurol, 258, 1042, 10.1007/s00415-010-5878-8 McDonald, 2017, Lower urinary tract symptoms in Parkinson's disease: prevalence, aetiology and management, Park Relat Disord, 35, 8, 10.1016/j.parkreldis.2016.10.024 Costa, 2016, Alexithymia in Parkinson's disease: a point of view on current evidence, Neurodegener Dis Manag, 6, 215, 10.2217/nmt-2016-0001 Pavy-Le Traon, 2018, Clinical rating scales for urinary symptoms in Parkinson disease: critique and recommendations, Mov Disord Clin Pract, 5, 479, 10.1002/mdc3.12636 Klietz, 2020, Alexithymia is associated with reduced quality of life and increased caregiver burden in Parkinson's disease, Brain Sci, 10, 401, 10.3390/brainsci10060401